Related Experiment Video
Updated: Jan 10, 2026

Isolation of Functional Cardiac Immune Cells
Published on: December 5, 2011
Cardiovascular manifestations in mast cell activation disease: key insights for cardiologists and angiologists
Wolfgang Taumann1, Gerhard J Molderings2
1Mast Cell Sciences Ltd., Meckenheim, Germany.
Insights
Mast cell activation disease, a genetic disorder, affects multiple organs due to inappropriate mast cell mediator release. Cardiologists must recognize its cardiovascular challenges, impacting up to 17% of patients.
Area of Science:
- Genetics
- Immunology
- Cardiology
Background:
- Mast cell activation disease (MCAD) is a genetic disorder with widespread clinical manifestations.
- It results from the release of mast cell mediators and abnormal mast cell accumulation.
- MCAD affects up to 17% of the population, frequently presenting diagnostic challenges in cardiology.
Purpose of the Study:
- To review the current understanding of MCAD.
- To highlight the cardiovascular manifestations and challenges of MCAD.
- To inform cardiologists and angiologists about this prevalent disease.
Main Methods:
- Literature review of current knowledge on MCAD.
- Focus on cardiovascular aspects and clinical implications.
- Synthesis of information for clinical practice.
Main Results:
- MCAD presents with diverse symptoms affecting nearly every organ system.
- Cardiovascular involvement is common but often unrecognized by specialists.
- A high prevalence necessitates increased awareness among cardiologists and angiologists.
Conclusions:
- MCAD is a complex genetic disease with significant cardiovascular implications.
- Enhanced knowledge of MCAD is crucial for cardiologists and angiologists.
- Early recognition and management of cardiovascular challenges in MCAD are essential.
Abstract:
Mast cell activation disease is a genetic disease entity characterized by a very pronounced clinical symptomatology with potential manifestations in virtually every organ and tissue. These arise from the inappropriate release of mast cell mediators and the accumulation of both morphologically normal and mutated mast cells. Owing to the high prevalence of the disease-estimated to be up to 17%-cardiologists and angiologists are frequently confronted with mast cell activation disease in their daily clinical practice, often without recognizing it. Therefore, every cardiologist and angiologist should possess basic knowledge about this disease and be aware of its cardiovascular challenges. This review summarizes the current state of knowledge on this highly complex disease, with a particular focus on the cardiovascular aspects.
More Related Videos
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina III: Clinical Manifestations and Assessment

